123 related articles for article (PubMed ID: 16986223)
1. Chronic graft-versus-host disease.
Galbizo E; Williams LA
Oncol Nurs Forum; 2006 Sep; 33(5):881-3. PubMed ID: 16986223
[No Abstract] [Full Text] [Related]
2. Topical tacrolimus in severe chronic graft-versus-host disease.
Heinemann C; Kaatz M; Schreiber G; Elsner P; Norgauer J
Acta Derm Venereol; 2005; 85(4):370-1. PubMed ID: 16191870
[No Abstract] [Full Text] [Related]
3. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
[No Abstract] [Full Text] [Related]
4. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
5. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
6. Many faces of graft-versus-host disease.
Peñas PF; Zaman S
Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830
[TBL] [Abstract][Full Text] [Related]
7. Cross-sensitivity reaction between tacrolimus and macrolide antibiotics.
Riley L; Mudd L; Baize T; Herzig R
Bone Marrow Transplant; 2000 Apr; 25(8):907-8. PubMed ID: 10808214
[TBL] [Abstract][Full Text] [Related]
8. [Massive pyogenic granuloma of the oral cavity during chronic graft-versus-host disease: treatment with local triamcinolone injection].
Adenis-Lamarre E; Fricain JC; Tabrizi R; Turlure P; Milpied N; Beylot-Barry M
Ann Dermatol Venereol; 2009 Nov; 136(11):818-20. PubMed ID: 19917438
[No Abstract] [Full Text] [Related]
9. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis in graft-versus-host disease.
Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
[TBL] [Abstract][Full Text] [Related]
12. [Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Koyama M; Matsuoka K; Kunisaki Y; Takeuchi M; Matsue K
Rinsho Ketsueki; 2004 Oct; 45(10):1115-8. PubMed ID: 15553047
[TBL] [Abstract][Full Text] [Related]
13. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
[No Abstract] [Full Text] [Related]
14. Graft-versus-host disease: case report and review of literature.
Jing X; Halat S; Meleg-Smith S
J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
[No Abstract] [Full Text] [Related]
16. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease.
Chung LW; Yeh SP; Hsieh CY; Liao YM; Huang HH; Lin CY; Chiu CF
Ann Hematol; 2008 May; 87(5):421-3. PubMed ID: 18040684
[No Abstract] [Full Text] [Related]
18. [Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion].
Li V; Molina L; Michallet M; Hostein J
Gastroenterol Clin Biol; 1992; 16(1):29-36. PubMed ID: 1537479
[No Abstract] [Full Text] [Related]
19. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
[No Abstract] [Full Text] [Related]
20. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M; Emi N; Naoe T; Sakamaki H; Takahashi S; Hirabayashi N; Hiraoka A; Kanda Y; Tanosaki R; Okamoto S; Iwato K; Atsuta Y; Hamajima N; Tanimoto M; Kato S
Bone Marrow Transplant; 2004 Aug; 34(4):331-7. PubMed ID: 15220958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
